• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Device Problem Fracture (1260)
Patient Problems Thrombosis (2100); No Consequences Or Impact To Patient (2199)
Event Date 11/28/2018
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that the stent fractured.A 6x120m eluvia stent was placed on (b)(6) 2018 in the superficial femoral artery (sfa).The index procedure was reported to be fine and there were no reported difficulties during deployment.The patient returned on (b)(6) 2018 for another procedure.Upon imaging, the eluvia stent appeared to be fractured in the middle of the stent and there was no blood flow through the stent.The physician performed an angiojet procedure to reopen the stent and restore blood flow.There were no patient complications reported.
 
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that the stent fractured.A 6x120m eluvia stent was placed on (b)(6) 2018 in the superficial femoral artery (sfa).The index procedure was reported to be fine and there were no reported difficulties during deployment.The patient returned on (b)(6) 2018 for another procedure.Upon imaging, the eluvia stent appeared to be fractured in the middle of the stent and there was no blood flow through the stent.The physician performed an angiojet procedure to reopen the stent and restore blood flow.There were no patient complications reported.It was further reported that after the stent fracture, thrombus was observed in the stent.The physician believes the stent fracture caused the thrombus to occur.There was no blood flow through the stent due to the thrombus.Angiojet was used to treat the thrombus and restore blood flow.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8173670
MDR Text Key130643338
Report Number2134265-2018-64426
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24657
Device Catalogue Number24657
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/23/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-